Carina Biotech is an Australian startup #immunotherapy company developing technologies to target solid #cancer Carina Biotech Pty Ltd is a start-up biotech company focused on research and IP development in T cell immunotherapies, particularly chimeric antigen receptor T cell (CAR-T) technologies.
Carina Biotech
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://carinabiotech.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
AddressLevel 5, Catherine Helen Spence Building, UniSA City West Campus, SA 5000AdelaideAustralia
Level 5, Catherine Helen Spence Building, UniSA City West Campus, SA 5000
Adelaide
Australia
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/carina-biotech” connections=”true” suffix=””]
Carina is developing technologies to expand the clinical utility and commercial market for CAR-T cell immunotherapies. Carina is developing injectable gel formulations for the transfer, isolation and controlled delivery of CAR-T cells to solid tumours.
In Apr 2018, Carina Biotech recieved $1 Mn funding from MTPConnect, the Medical Technology, Biotechnology and Pharmaceutical (MTP) Industry Growth Centre.